De novo severe pemphigus vulgaris following SARS-CoV-2 vaccination with BBIBP-CorV.

Saffarian, Zahra; Samii, Rana; Ghanadan, Alireza; Vahidnezhad, Hassan

Saffarian, Zahra; Samii, Rana; Ghanadan, Alireza; Vahidnezhad, Hassan.

Saffarian Z; Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran.
Samii R; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ghanadan A; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Vahidnezhad H; Department of Dermatopathology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Dermatol Ther ; 35(6): e15448, 2022 06.

Article in English | MEDLINE | ID: covidwho-1741369

Subject(s)

COVID-19 Vaccines; COVID-19; Pemphigus; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Pemphigus/chemically induced; Pemphigus/diagnosis; SARS-CoV-2; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pemphigus / COVID-19 Vaccines / COVID-19 Type of study: Case report / Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Dth.15448

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google